BIOTECH AND PHARMANEWS

‘I’m a Coronary heart specialist; I’m Primitive to Doing Issues’: What We Heard This Week

“I’m a coronary heart specialist; I’m oldschool to doing things.” — FDA Commissioner Robert Califf, MD, within the route of a press briefing discussing the company’s proposal to ban menthol in cigarettes and varied tobacco merchandise.

“Or not it’s genuine in point of fact critical to earn the discover out that we beget way more tools within the toolkit now.” — Kathy Yang, PharmD, of the College of California San Francisco, on urging suppliers to refer to patients about reaching out after they’re ill to supply a take dangle of to earn entry to to Paxlovid.

“Why these telemedicine operations soundless exist is totally perplexing.” — Cut Sawyer, MD, MBA, of the College of California Davis, on products and services that supply prescriptions for unproven therapies, fancy ivermectin, for COVID-19.

“I peek mild at the tunnel. I genuine sort not know whether or not or not it’s a explain or the solar.” — North Carolina Sen. Richard Burr (R) discussing the enlighten of the pandemic within the route of a Senate committee listening to on re-authorizing FDA customers costs.

“It does beget moderately of a flavor of, here we shuffle again.” — Jacob Lemieux, MD, PhD, of Massachusetts Identical outdated Effectively being facility, on South Africa’s unique surge in COVID conditions.

“There’s no explicit clarification why emergency contraception pills must be taken after intercourse.” — Erica Cahill, MD, of Stanford College in California, on unique study inspecting an oral drug combination as pre-intercourse delivery control.

“Here’s a theme all the way by all of treatment, the ‘lumpers and splitters.'” — David Dudzinski, MD, JD, of Massachusetts Identical outdated Effectively being facility, discussing unique pointers that launched unique categories for coronary heart failure with intermediate and improved ejection allotment.

“It charges fancy $5 to exercise this, so why not give it a are attempting?” — Nicole Schmitt, MD, of Emory College in Atlanta, on the exercise of topical antisepsis agents earlier than complex facial flap reconstruction as a strategy of lowering surgical location infections.

Content Protection by DMCA.com

Back to top button